Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Canadian Journal of Gastroenterology
Volume 27, Issue 5, Pages 273-280
http://dx.doi.org/10.1155/2013/512624
Original Article

Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy

Kelly W Burak,1 Mark G Swain,1 Tania Santodomino-Garzon,1 Samuel S Lee,1 Stefan J Urbanski,2 Alexander I Aspinall,1 Carla S Coffin,1 and Robert P Myers1

1Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada
2Department of Pathology, University of Calgary, Calgary, Alberta, Canada

Received 2 December 2012; Accepted 9 December 2012

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kelly W Burak, Mark G Swain, Tania Santodomino-Garzon, et al., “Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy,” Canadian Journal of Gastroenterology, vol. 27, no. 5, pp. 273-280, 2013. https://doi.org/10.1155/2013/512624.